Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021.

Susan M Swetter,John A Thompson,Mark R Albertini,Christopher A Barker,Joel Baumgartner,Genevieve Boland,Bartosz Chmielowski,Dominick DiMaio,Alison Durham,Ryan C Fields,Martin D Fleming,Anjela Galan,Brian Gastman,Kenneth Grossmann,Samantha Guild,Ashley Holder,Douglas Johnson,Richard W Joseph,Giorgos Karakousis,Kari Kendra,Julie R Lange,Ryan Lanning,Kim Margolin,Anthony J Olszanski,Patrick A Ott,Merrick I Ross,April K Salama,Rohit Sharma,Joseph Skitzki,Jeffrey Sosman,Evan Wuthrick,Nicole R McMillian,Anita M Engh

Journal of the National Comprehensive Cancer Network : JNCCN（2021）

Cited 0|Views23
No score
Abstract
Over the past few years, the NCCN Guidelines for Melanoma: Cutaneous have been expanded to include pathways for treatment of microscopic satellitosis (added in v2.2020), and the following Principles sections: Molecular Testing (added in v2.2019), Systemic Therapy Considerations (added in v2.2020), and Brain Metastases Management (added in v3.2020). The v1.2021 update included additional modifications of these sections and notable revisions to Principles of: Pathology, Surgical Margins for Wide Excision of Primary Melanoma, Sentinel Lymph Node Biopsy, Completion/Therapeutic Lymph Node Dissection, and Radiation Therapy. These NCCN Guidelines Insights discuss the important changes to pathology and surgery recommendations, as well as additions to systemic therapy options for patients with advanced disease.
More
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined